Background Background Polyuria is common in
Polyuria is common in patients with bipolardisorder treated with patients with bipolardisorder treated with lithium.However, the risk factors for lithium.However, the risk factors for polyuria in these patients have not been polyuria in these patients have not been established. established.
Aims Aims To estimate the prevalence of
To estimate the prevalence of polyuria associated with the use of lithium polyuria associated with the use of lithium and to identify additional risk factors. and to identify additional risk factors.
Method Method A 4-month prospective
A 4-month prospective follow-up study in an out-patient lithium follow-up study in an out-patient lithium clinic.The 75 participants were asked to clinic.The 75 participants were asked to provide 24-h urine samples; polyuria was provide 24-h urine samples; polyuria was defined as a urine volume greater than 3 defined as a urine volume greater than 3 litres per 24 h.Risk factors examined litres per 24 h.Risk factors examined included demographic variables, included demographic variables, medications and medical comorbidities. medications and medical comorbidities.
Results

Results The prevalence of polyuria
The prevalence of polyuria among lithium users was 37%. among lithium users was 37%. Concomitant use of serotonergic Concomitant use of serotonergic antidepressants was strongly associated antidepressants was strongly associated with polyuria (odds ratio 4.25,95% CI with polyuria (odds ratio 4.25,95% CI 1.15^15.68) compared with patients not 1.15^15.68) compared with patients not using these agents. using these agents.
Conclusions
Conclusions Our data confirm the Our data confirm the high prevalence of lithium-induced high prevalence of lithium-induced polyuria. Physicians should be aware that polyuria. Physicians should be aware that concurrent use of serotonergic concurrent use of serotonergic antidepressants and lithium significantly antidepressants and lithium significantly enhances the risk of its occurrence. enhances the risk of its occurrence. Although limited polyuria is not harmful, it Although limited polyuria is not harmful, it may be troublesome for the patient.In may be troublesome for the patient.In many cases cessation of lithium therapy is many cases cessation of lithium therapy is not an option because of difficulty in not an option because of difficulty in controlling the manic or depressive controlling the manic or depressive symptoms. symptoms.
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None. . Since the introduction of lithium therapy a variety of duction of lithium therapy a variety of studies have investigated its side-effects, studies have investigated its side-effects, such as cutaneous reactions, thyroid dissuch as cutaneous reactions, thyroid disorders and urine-concentration abnormalorders and urine-concentration abnormalities. Polyuria has been estimated to occur ities. Polyuria has been estimated to occur in 15-40% of all patients treated with in 15-40% of all patients treated with lithium. Clinically established nephrogenic lithium. Clinically established nephrogenic diabetes insipidus has been found in about diabetes insipidus has been found in about 12% of all patients treated with lithium 12% of all patients treated with lithium (Boton (Boton et al  et al, 1987) . , 1987). Early studies found that 24-h urine Early studies found that 24-h urine volumes were increased and urinary osmovolumes were increased and urinary osmolality was decreased in patients using lality was decreased in patients using lithium concurrently with psychotropic lithium concurrently with psychotropic medication (Bone medication (Bone et al et al, 1980; Bendz , 1980; Bendz et al et al, , 1983). However, these studies were con-1983). However, these studies were conducted before the introduction of many ducted before the introduction of many new psychotropic drugs, especially the new psychotropic drugs, especially the second-generation antidepressants. More second-generation antidepressants. More recently, it has been found that patients recently, it has been found that patients treated with both lithium and unspecified treated with both lithium and unspecified psychotropic drugs had a lower urinary psychotropic drugs had a lower urinary concentrating capacity and glomerular concentrating capacity and glomerular filtration rate than patients taking lithium filtration rate than patients taking lithium alone (Bendz alone (Bendz et al et al, 1994) . , 1994). The objectives of our study were to The objectives of our study were to estimate the prevalence of polyuria assoestimate the prevalence of polyuria associated with the use of lithium and to ciated with the use of lithium and to identify additional risk factors, especially identify additional risk factors, especially concurrently used medication, that predisconcurrently used medication, that predispose patients on lithium to develop pose patients on lithium to develop polyuria. polyuria.
METHOD METHOD
Setting and study population Setting and study population A prospective follow-up study was designed A prospective follow-up study was designed to assess the prevalence and determinants to assess the prevalence and determinants of polyuria among lithium users. The of polyuria among lithium users. The source population of our study was all psysource population of our study was all psychiatric patients with a diagnosis of affecchiatric patients with a diagnosis of affective disorder attending the lithium clinic tive disorder attending the lithium clinic of a psychiatry department within the of a psychiatry department within the period September 2001 to January 2002. period September 2001 to January 2002. All patients using lithium for at least 1 All patients using lithium for at least 1 month were asked to participate in this month were asked to participate in this study during their routine visits (scheduled study during their routine visits (scheduled once every 3 months) to the out-patient once every 3 months) to the out-patient lithium clinic in the psychiatry department. lithium clinic in the psychiatry department. All data were anonymously processed and All data were anonymously processed and all participants gave written informed all participants gave written informed consent for inclusion in this study. consent for inclusion in this study.
Outcome Outcome
The primary end-point of this study was the The primary end-point of this study was the presence of polyuria, defined quantitively presence of polyuria, defined quantitively as a daily (24-h) urine volume greater than as a daily (24-h) urine volume greater than 3 litres (Baylis, 1996) . Patients were given 3 litres (Baylis, 1996) . Patients were given clear instructions (both verbal and written) clear instructions (both verbal and written) regarding the collection of the urine regarding the collection of the urine samples and were encouraged to contact samples and were encouraged to contact us when there were any questions. The us when there were any questions. The volume of the urine was determined and volume of the urine was determined and creatinine concentrations and osmolality creatinine concentrations and osmolality were measured by standard laboratory were measured by standard laboratory methods. If the urinary creatinine content methods. If the urinary creatinine content was less than 6.0 mmol per day, the 24-h was less than 6.0 mmol per day, the 24-h urine collection was considered inaccurate. urine collection was considered inaccurate. Fluid intake was estimated by means of a Fluid intake was estimated by means of a written questionnaire, asking patients to written questionnaire, asking patients to report fluid consumption during the 24-h report fluid consumption during the 24-h urine sampling period. urine sampling period.
Determinants Determinants
Serum lithium concentrations were meaSerum lithium concentrations were measured in the routine laboratory therapeutic sured in the routine laboratory therapeutic drug monitoring programme. The cumuladrug monitoring programme. The cumulative amount of ingested lithium was tive amount of ingested lithium was expressed as the product of time on lithium expressed as the product of time on lithium and the average daily dosage, determined and the average daily dosage, determined from medical records. Patients were defined from medical records. Patients were defined as current drug users if the prescription as current drug users if the prescription lasted until the day of the visit to the lasted until the day of the visit to the lithium clinic. A psychiatrist or nurse lithium clinic. A psychiatrist or nurse practitioner obtained drug prescription practitioner obtained drug prescription data during the patient's visit, and the data during the patient's visit, and the community pharmacy was consulted. Data community pharmacy was consulted. Data on comorbidity and smoking behaviour on comorbidity and smoking behaviour were obtained from medical records. were obtained from medical records.
Antidepressant drugs were classified Antidepressant drugs were classified into two groups. The first group consisted into two groups. The first group consisted of antidepressants predominantly acting of antidepressants predominantly acting on the serotonergic system (serotonergic on the serotonergic system (serotonergic antidepressants), which included clomipantidepressants), which included clomipramine, fluoxetine, paroxetine, sertraline, ramine, fluoxetine, paroxetine, sertraline, trazodone and venlafaxine. The second trazodone and venlafaxine. The second group consisted of antidepressants that group consisted of antidepressants that have less potency to inhibit the serohave less potency to inhibit the serotonin reuptake mechanism, including tonin reuptake mechanism, including amitriptyline, imipramine, maprotiline and amitriptyline, imipramine, maprotiline and nortriptyline. Clomipramine, trazodone nortriptyline. Clomipramine, trazodone and venlafaxine were included in the first and venlafaxine were included in the first group because these compounds are known group because these compounds are known to be potent antagonists of the serotonin to be potent antagonists of the serotonin reuptake mechanism (Tatsumi reuptake mechanism (Tatsumi et al et al, 1997). , 1997).
Data analysis Data analysis
For all patients the prevalence of each charFor all patients the prevalence of each characteristic on the inclusion date was deteracteristic on the inclusion date was determined. An analysis of variance (Student's mined. An analysis of variance (Student's t t-test) was used to compare frequencies of -test) was used to compare frequencies of continuous variables for participants with continuous variables for participants with and without polyuria. Differences in proand without polyuria. Differences in proportions of categorical variables were asportions of categorical variables were assessed for significance by a chi-squared test. sessed for significance by a chi-squared test.
To estimate a possible association To estimate a possible association between potential risk factors and polyuria, between potential risk factors and polyuria, crude and adjusted odds ratios were calcucrude and adjusted odds ratios were calculated as measures of relative risk using lated as measures of relative risk using logistic regression and were presented logistic regression and were presented with a 95% confidence interval. The final with a 95% confidence interval. The final logistic regression model included age and logistic regression model included age and gender and all univariately associated (at gender and all univariately associated (at P P4 40.1) risk factors for polyuria. In order 0.1) risk factors for polyuria. In order to study and adjust for potential conto study and adjust for potential confounding factors, additional data on founding factors, additional data on concomitant concomitant medication (antidepressants, medication (antidepressants, diuretics, antihypertensives, neuroleptics) diuretics, antihypertensives, neuroleptics) and comorbidity (diabetes mellitus, hyperand comorbidity (diabetes mellitus, hypertension, thyroid disease) were collected. tension, thyroid disease) were collected. All calculations were carried out using the All calculations were carried out using the Statistical Package for the Social Sciences, Statistical Package for the Social Sciences, version 10.0. version 10.0.
RESULTS RESULTS
The final study population consisted of 75 The final study population consisted of 75 patients. All these patients gave informed patients. All these patients gave informed consent and collected adequate 24-h urine consent and collected adequate 24-h urine samples. Six patients were excluded for samples. Six patients were excluded for various reasons. Table 1 summarises the various reasons. Table 1 summarises the characteristics of the patients, stratified characteristics of the patients, stratified according to presence or absence of polyaccording to presence or absence of polyuria. The mean age of the patients was 52 uria. The mean age of the patients was 52 years; the women were slightly older (54 years; the women were slightly older (54 years years v v. 49 years) but this was not statisti-. 49 years) but this was not statistically significant ( cally significant (P P¼0.069). In the group 0.069). In the group as a whole, 46 patients (61%) were female as a whole, 46 patients (61%) were female and the average lithium treatment duration and the average lithium treatment duration was 4.7 years. For 44 patients (59%) the was 4.7 years. For 44 patients (59%) the primary psychiatric indication for lithium primary psychiatric indication for lithium was bipolar affective disorder and for 31 was bipolar affective disorder and for 31 patients (41%) it was major depressive dispatients (41%) it was major depressive disorder. There was no diagnosis of schizoorder. There was no diagnosis of schizoaffective disorder. In the group with major affective disorder. In the group with major depressive disorder, lithium was always depressive disorder, lithium was always added to an antidepressant as an augmenadded to an antidepressant as an augmentation strategy. In the group of patients tation strategy. In the group of patients with bipolar (I and II) disorder an antiwith bipolar (I and II) disorder an antidepressant was added when lithium alone depressant was added when lithium alone did not prevent depression. The lithium did not prevent depression. The lithium serum concentrations were not statistically serum concentrations were not statistically different between the two patient groups different between the two patient groups ( (P P¼0.258). Twenty-eight patients (37%) 0.258). Twenty-eight patients (37%) were identified as having polyuria. Outwere identified as having polyuria. Outcome parameters for patients with and come parameters for patients with and without polyuria are presented in Table 2 . without polyuria are presented in Table 2 . There was no difference between the two There was no difference between the two groups in 24-h creatinine excretion. In both groups in 24-h creatinine excretion. In both patient groups, the intake volume equalled patient groups, the intake volume equalled the 24-h urine output volume. Half of the the 24-h urine output volume. Half of the patients with polyuria were current users patients with polyuria were current users of serotonergic antidepressants, whereas of serotonergic antidepressants, whereas less than a quarter of the non-polyuria less than a quarter of the non-polyuria patients (23%) were current users of these patients (23%) were current users of these drugs. Users of serotonergic antidepressants drugs. Users of serotonergic antidepressants had a three times higher risk (unadjusted had a three times higher risk (unadjusted relative risk 3.06, 95% CI 1.04-9.00) for relative risk 3.06, 95% CI 1.04-9.00) for polyuria compared with non-recipients of polyuria compared with non-recipients of these agents (Table 3) . Concurrent use of these agents (Table 3) . Concurrent use of benzodiazepines, hypertension, lithium benzodiazepines, hypertension, lithium dosing frequency and smoking were not dosing frequency and smoking were not significantly associated with polyuria. significantly associated with polyuria. Thyroid disorders were inversely associated Thyroid disorders were inversely associated with polyuria, but this was not statistically with polyuria, but this was not statistically significant. significant.
After adjustment for potential conAfter adjustment for potential confounding factors, the clear association founding factors, the clear association between the use of serotonergic antidepresbetween the use of serotonergic antidepressants and polyuria in this cohort of lithium sants and polyuria in this cohort of lithium users remains: adjusted relative risk 4.25 users remains: adjusted relative risk 4.25 (95% CI 1.15-15.68) compared with non-(95% CI 1.15-15.68) compared with nonrecipients. The most frequently used recipients. The most frequently used serotonergic antidepressants were clomipserotonergic antidepressants were clomipramine and paroxetine. Stratified analysis ramine and paroxetine. Stratified analysis showed that patients using lithium for 3 showed that patients using lithium for 3 years or more were at a higher risk (OR years or more were at a higher risk (OR¼ 2.65, 95% CI 0.87-8.07) of polyuria 2.65, 95% CI 0.87-8.07) of polyuria 3 2 0 3 2 0 
Diabetes mellitus:
Hypertension: Hypertension: n n (%) (%) 9 (12) 9 (12) 3 (11) 3 (11) 6 (13) 6 (13) compared with patients exposed for a compared with patients exposed for a shorter period, but again that was not shorter period, but again that was not statistically significant. statistically significant.
DISCUSSION DISCUSSION
Major findings Major findings
In this prospective study we found an overIn this prospective study we found an overall prevalence of relevant polyuria of 37% all prevalence of relevant polyuria of 37% in patients treated with lithium. The most in patients treated with lithium. The most important finding was that patients on important finding was that patients on lithium concurrently using serotonergic lithium concurrently using serotonergic antidepressants were four times more likely antidepressants were four times more likely to develop polyuria than non-recipients of to develop polyuria than non-recipients of these drugs. Long-term lithium treatment these drugs. Long-term lithium treatment was also associated with a higher risk of was also associated with a higher risk of polyuria, but this was not statistically polyuria, but this was not statistically significant. significant.
Context of the results
Polyuria is a frequent complication in Polyuria is a frequent complication in patients receiving lithium. 1994) , who reported that (1994), who reported that patients treated with both lithium and psypatients treated with both lithium and psychotropic agents had a decreased urinary chotropic agents had a decreased urinary concentration capacity and increased 24-h concentration capacity and increased 24-h urinary volume. In their study, however, urinary volume. In their study, however, the psychotropic agents were not assessed the psychotropic agents were not assessed separately and no relative risk estimate separately and no relative risk estimate was given. was given.
High serum levels of lithium have been High serum levels of lithium have been reportedly associated with significantly reportedly associated with significantly more cases of polyuria than have low serum more cases of polyuria than have low serum levels (Maj levels (Maj et al et al, 1986). However, our , 1986). However, our study found no statistically significant study found no statistically significant relationship between serum lithium levels relationship between serum lithium levels and polyuria. The small number of cases and polyuria. The small number of cases might be a reason for this observation. It might be a reason for this observation. It has been suggested that lithium administrahas been suggested that lithium administration in a single daily dose rather than multition in a single daily dose rather than multiple daily doses might accelerate the tubular ple daily doses might accelerate the tubular regeneration process and decrease the risk regeneration process and decrease the risk of polyuria (Bowen of polyuria (Bowen et al et al, 1991). However, , 1991). However, researchers are not unanimous. O'Donovan researchers are not unanimous. O'Donovan et al et al (1993) found that switching to a sin- (1993) found that switching to a single daily dose of lithium did not reduce gle daily dose of lithium did not reduce the 24-h urine volume. In our study urine the 24-h urine volume. In our study urine volume was not significantly related to volume was not significantly related to the dosing regimen. Both thiazides and the dosing regimen. Both thiazides and potassium-sparing diuretics have been potassium-sparing diuretics have been shown to ameliorate lithium-induced shown to ameliorate lithium-induced polyuria (Martin, 1993). Diuretics were polyuria (Martin, 1993). Diuretics were not used in our patient population. not used in our patient population.
Smoking impairs urine excretion by Smoking impairs urine excretion by increasing endogenous arginine vasopressin increasing endogenous arginine vasopressin (AVP) secretion (Allon (AVP) secretion (Allon et al et al, 1990). How-, 1990). However, in our study smoking was not found ever, in our study smoking was not found to be associated with a decreased urinary to be associated with a decreased urinary volume. Patients with thyroid disorder volume. Patients with thyroid disorder seemingly had a lower risk of polyuria. seemingly had a lower risk of polyuria. No possible pharmacological explanation No possible pharmacological explanation was found in the research literature. was found in the research literature.
Pharmacological explanation Pharmacological explanation
The mechanism of lithium-induced polyThe mechanism of lithium-induced polyuria is biologically explicable. Under uria is biologically explicable. Under normal physiological circumstances AVP normal physiological circumstances AVP binds to vasopressin type 2 receptors binds to vasopressin type 2 receptors located in the basolateral membrane of located in the basolateral membrane of the renal collecting-duct cells. This binding the renal collecting-duct cells. This binding initiates a cascade, triggering the insertion initiates a cascade, triggering the insertion of vesicles containing the aquaporin-2 of vesicles containing the aquaporin-2 water channel into the normally watertight water channel into the normally watertight apical membrane, to cause increased water apical membrane, to cause increased water permeability followed by water resorption, permeability followed by water resorption, leading to concentrated urine production leading to concentrated urine production (Deen & Knoers, 1998). In rat models (Deen & Knoers, 1998). In rat models lithium appeared to cause polyuria through lithium appeared to cause polyuria through downregulation of aquaporin-2 expression downregulation of aquaporin-2 expression (Marples (Marples et al . It has been suggested that lithium acts by inhibiting adenylate cyclase activity acts by inhibiting adenylate cyclase activity in the collecting-duct cells, preventing the in the collecting-duct cells, preventing the production of cyclic adenosine monoproduction of cyclic adenosine monophosphate (cAMP), the second messenger phosphate (cAMP), the second messenger for vasopressin. for vasopressin.
A pharmacological explanation for A pharmacological explanation for serotonergically induced polyuria has not serotonergically induced polyuria has not been explored. So far, it has been accepted been explored. So far, it has been accepted that antidepressants are effective through that antidepressants are effective through interaction with certain key receptors in interaction with certain key receptors in serotonergic, noradrenergic and/or dopaserotonergic, noradrenergic and/or dopaminergic neurotransmission systems (Stahl, minergic neurotransmission systems (Stahl, 1998 , 1994) ; however, these trials , 1994); however, these trials were not designed to estimate the prevawere not designed to estimate the prevalence of such adverse effects, including lence of such adverse effects, including polyuria. polyuria.
Serotonergic antidepressants are assoSerotonergic antidepressants are associated with urinary problems in daily cliniciated with urinary problems in daily clinical practice. It has been recorded that cal practice. It has been recorded that serotonergic drugs can induce hyposerotonergic drugs can induce hyponatraemia (Movig natraemia (Movig et al  et al, 2002) , supposedly , 2002), supposedly by inappropriate secretion of antidiuretic by inappropriate secretion of antidiuretic hormone, which eventually leads to a hormone, which eventually leads to a decrease in urine production. Since we decrease in urine production. Since we found a statistically significant additional found a statistically significant additional effect of serotonergic antidepressants on effect of serotonergic antidepressants on lithium-induced polyuria, it is likely that lithium-induced polyuria, it is likely that the effect of serotonergic medication on the effect of serotonergic medication on lithium-induced polyuria is explained by a lithium-induced polyuria is explained by a drug interaction at the tubular level. drug interaction at the tubular level.
Limitations of the study design Limitations of the study design
Our study has some potential limitations. Our study has some potential limitations. Selection bias is a potential threat to study Selection bias is a potential threat to study validity and occurs whenever the inclusion validity and occurs whenever the inclusion of patients is in some way associated with of patients is in some way associated with the outcome of interest. However, the psythe outcome of interest. However, the psychiatrists were not informed about the chiatrists were not informed about the primary objective of this study; they only primary objective of this study; they only recruited the patients and instructed them recruited the patients and instructed them in the urine collection protocol. It is therein the urine collection protocol. It is therefore unlikely that users of serotonergic fore unlikely that users of serotonergic agents were more frequently included than agents were more frequently included than patients using other (or no) antidepressants. patients using other (or no) antidepressants. A second concern is the possibility of A second concern is the possibility of observer bias. This was minimised by observer bias. This was minimised by medical record review after the patient medical record review after the patient had visited the lithium clinic to verify the had visited the lithium clinic to verify the study forms filled in by the psychiatrist. study forms filled in by the psychiatrist.
Although the study was sufficiently Although the study was sufficiently powerful to detect a number of risk factors, powerful to detect a number of risk factors, it was somewhat limited by its small size. it was somewhat limited by its small size. The wide confidence intervals around some The wide confidence intervals around some of the odds ratios are a reflection of this of the odds ratios are a reflection of this limitation. limitation.
A dichotomous cut-off point of 3 litres A dichotomous cut-off point of 3 litres of urine per day for polyuria has been used of urine per day for polyuria has been used in the logistic regression model. Such a cutin the logistic regression model. Such a cutoff level is widely accepted for research puroff level is widely accepted for research purposes (Baylis, 1996), but it still might be poses (Baylis, 1996) , but it still might be arbitrary. Therefore, we also performed arbitrary. Therefore, we also performed analyses using continuous measures of analyses using continuous measures of 24-h urine output as the dependent vari-24-h urine output as the dependent variable, i.e. linear regression analysis. We able, i.e. linear regression analysis. We found that patients who had been treated found that patients who had been treated with selective serotonin reuptake inhibitors with selective serotonin reuptake inhibitors (SSRIs) and lithium salts concurrently had (SSRIs) and lithium salts concurrently had significantly greater urinary output (mean significantly greater urinary output (mean difference 941 ml, 95% CI 280-1601; difference 941 ml, 95% CI 280-1601; P P¼0.006) than patients treated with 0.006) than patients treated with lithium only. The logistic regression model lithium only. The logistic regression model provided a comparable statistically signifiprovided a comparable statistically significant cant P P value, and in essence the same result, value, and in essence the same result, for the association between polyuria and for the association between polyuria and treatment with both lithium and SSRIs treatment with both lithium and SSRIs compared with lithium use only. compared with lithium use only. 
